Global companies line up to trial FGO’s ROSIE AI
Artificial intelligence systems known as Chatbots have been on the rise in the past 12 months, as businesses look to this new intelligence to improve customer experience.
Chatbots interact with users via messaging, text, or speech with the market expected to grow exponentially: according to Grand View Research, the market will be worth $1.23 billion by 2025 – a compounded annual growth rate (CAGR) of 24.3%.
One Australian company leading the way in the growth of AI, is Flamingo AI (ASX:FGO). The company has been busy over recent months assisting several global entities to trial the company’s virtual assistant ROSIE.
Flamingo AI says ROSIE is more than just a Chatbot. It is a ‘Cognitive Virtual Sales Assistant,’ utilising machine learning to observe and build on her knowledge.
The AI has been designed as a ‘journey assist’ platform, pre-configured with product information, applications, quotation questions, payment gateways, specific to the particular company that adopts the technology.
CUA is the most recent company to trial FGO’s solution.
The Brisbane-based banking-insurance outfit CUA is trialling ROSIE for three months from April on CUA’s health insurance products. Up to 1500 customers will deal with ROSIE as CUA seeks to gain a first-mover advantage within this industry.
On integrating the AI, CUA Health head Philip Fraser said, “If we’re not there and we’re not providing this technology ... then arguably somebody else will be the adopter of this technology.”
CUA is just the latest in a string of companies to trial ROSIE as the increased interest in ROSIE in the US and Australia quickly expands.
AMP and Chubb are also trialling Flamingo AI’s Cognitive Virtual Assistant platform.
“We are trialling the latest technology to ensure our interaction with customers through our online support platforms is best practice,” an AMP spokesman told The Australian Financial Review.
AMP’s support comes on the back of growing interest from the finance and insurance sectors with online loan provider DirectMoney also trialling the platform, with ROSIE to be used to guide customers through secured and unsecured personal loan applications.
In the US, FGO’s relationship with Nationwide is progressing well with the insurer’s customers now interacting with FGO’s virtual assistant platform for its Guaranteed Retirement Income product, with discussions in train to cater to other business divisions. Additionally, Flamingo AI has two other Fortune 100 US based insurers as clients and a strong sales pipeline in North America.
It should be noted however that this remains a speculative stock and investors should seek professional financial advice if considering this stock for your portfolio.
FGO CEO Dr Catriona Wallace is confident that ROSIE will have a big impact. Dr Wallace told Finfeed: “Artificial Intelligence is the fastest growing technology sector and we are well ahead of the market. We have developed our own IP and have proven business results, which a lot of our competitors have failed to do. On the back of a successful Capital Raise in December 2017, we are laser focused on sales and revenue generation.”
When the experts at Next Investors have a stock pick, it may pay to listen.
The Next Investors have been investing in ASX small cap stocks for years, with their best small cap picks yielding returns of 1,200%, 1,120%, 900% and 678%.
They have just revealed their hand-picked, FY2021 stock portfolio of high conviction long-term investments.
Click the link below to see what they are currently investing in.
S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information only. Any advice is general advice only. Neither your personal objectives, financial situation nor needs have been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice.
Conflict of Interest Notice
S3 Consortium Pty Ltd does and seeks to do business with companies featured in its articles. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this article. Investors should consider this article as only a single factor in making any investment decision. The publishers of this article also wish to disclose that they may hold this stock in their portfolios and that any decision to purchase this stock should be done so after the purchaser has made their own inquires as to the validity of any information in this article.
The information contained in this article is current at the finalised date. The information contained in this article is based on sources reasonably considered to be reliable by S3 Consortium Pty Ltd, and available in the public domain. No “insider information” is ever sourced, disclosed or used by S3 Consortium.